Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Net Income - Minority (2022 - 2023)

Historic Net Income - Minority for Zentalis Pharmaceuticals (ZNTL) over the last 2 years, with Q4 2023 value amounting to -$107000.0.

  • Zentalis Pharmaceuticals' Net Income - Minority rose 5158.37% to -$107000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was -$107000.0, marking a year-over-year increase of 5158.37%. This contributed to the annual value of -$107000.0 for FY2023, which is 5158.37% up from last year.
  • Latest data reveals that Zentalis Pharmaceuticals reported Net Income - Minority of -$107000.0 as of Q4 2023, which was up 5158.37% from -$129000.0 recorded in Q3 2023.
  • In the past 5 years, Zentalis Pharmaceuticals' Net Income - Minority registered a high of -$107000.0 during Q4 2023, and its lowest value of -$221000.0 during Q4 2022.